Sarah M. Temkin, MD

Formulary Frontlines®

PARP Inhibitors for Ovarian Cancer: Who and When, And Can We Afford It?

07/20/2018

Sarah M Temkin, MD, and Don Dizon, MD, discuss the benefits of PARP inhibitors for treating ovarian cancer and why effectiveness, toxicity, safety, and cost must be balanced for an individual patient to determine the right PARP inhibitor for...

Sarah M Temkin, MD, and Don...

07/20/2018

First Report Managed Care

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Sarah M. Temkin, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products